Association of E-selectin with hematological, hormonal levels and plasma proteins in children with end stage renal disease

Authors
Rokhsareh Meamar 1
Mohammad Shafiei 2
Amin Abedini 2
Mohammad Reza Aghaye Ghazvini 3
Peyman Roomizadeh 2
Shahram Taheri 4
Alaleh Gheissari 4
1 Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan; Department of Medical Sciences, Najafabad Branch, Islamic Azad University, Isfahan, Iran
2 Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
3 Isfahan Center of Health Research, Isfahan University of Medical Sciences, Isfahan; National Institute of Health Research, Tehran University of Medical Sciences, Tehran, Iran
4 National Institute of Health Research, Tehran University of Medical Sciences, Tehran, Iran
Abstract
Background: Hypercoagulable state is a common serious problem in patients with end-stage renal disease (ESRD). ESRD patients are in a condition of chronic inflammation. An increased level of E-selectin, “a key adhesion molecule that regulates leukocyte bindings to endothelium at damaged sites,” accompanies the higher risk of inflammation in ESRD patients. We aimed to investigate the possible correlation among E-selectin as an adhesion molecule, coagulation factors, and inflammatory factors in children with ESRD.
Materials and Methods: Thirty-five child patients with ESRD who had been on regular dialysis treatment were registered in our study. Nighteen sex- and age-matched healthy volunteers were used as the control group. Laboratory tests were requested for the evaluation of hematological and biochemical parameters, and parathyroid hormone (PTH), and for coagulation state; fibrinogen, protein C, and protein S were measured. The enzyme-linked immunosorbent assay (ELISA) (Biomerica, CA, and IDS, UK). for serum E-selectin assay was provided by R and D Systems (Abingdon, UK).




Results: Hemoglubolin (Hb), blood urea nitrogen (BUN), creatinine, calcium, PTH, triglyceride (TG) concentrations in serum as well as E-selectin showed significant difference between the two study groups, as indeed was expected. Serum E-selectin was significantly higher (P value = 0.033) in dialysis patients than in healthy subjects. E-selectin was positively correlated only with phosphorus in ESRD children (r = 0.398,P = 0.018). No association was found for other parameters.
Conclusion: Although in our study circulating E-selectin concentration “as an inflammatory maker” is independently positively associated with limited blood markers, for better evaluation, well-designed cohort studies should be examined in ESRD children.

Keywords

1.
Tripepi G, Mallamaci F, Zoccali C. Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: Searching for the best risk marker by multivariate modeling. J Am Soc Nephrol 2005;16(Suppl 1):S83-8.  Back to cited text no. 1
    
2.
Zoccali C, Mallamaci F, Tripepi G. Inflammation and atherosclerosis in end-stage renal disease. Blood Purif 2003;21:29-36.  Back to cited text no. 2
    
3.
Stenvinkel P. Inflammation in end-stage renal failure: Could it be treated? Nephrol Dial Transplant 2002;17(Suppl 8):33-8; discussion 40.  Back to cited text no. 3
    
4.
Martín-Ventura JL, Ortego M, Esbrit P, Hernández-Presa MA, Ortega L, Egido J. Possible role of parathyroid hormone-related protein as a proinflammatory cytokine in atherosclerosis. Stroke 2003;34:1783-9.  Back to cited text no. 4
    
5.
Bostom AG, Culleton BF. Hyperhomocysteinemia in chronic renal disease. J Am Soc Nephrol 1999;10:891-900.  Back to cited text no. 5
    
6.
Malatino LS, Stancanelli B, Cataliotti A, Bellanuova I, Fatuzzo P, Rapisarda F, et al. Circulating E-selectin as a risk marker in patients with end-stage renal disease. J Intern Med 2007;262:479-87.  Back to cited text no. 6
    
7.
Testa A, Benedetto FA, Spoto B, Pisano A, Tripepi G, Mallamaci F, et al. The E-selectin gene polymorphism and carotid atherosclerosisin end-stage renal disease. Nephrol Dial Transplant 2006;21:1921-6.  Back to cited text no. 7
    
8.
Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-34.  Back to cited text no. 8
    
9.
Zoccali C, Mallamaci F, Tripepi G. Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int Suppl 2003;S105-110.  Back to cited text no. 9
    
10.
Stam F, van Guldener C, Schalkwijk CG, ter Wee PM, Donker AJ, Stehouwer CD. Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity. Nephrol Dial Transplant 2003;18:892-8.  Back to cited text no. 10
    
11.
Vanhoutte PM. Endothelial dysfunction and atherosclerosis. Eur Heart J 1997;18(Suppl E):E19-29.  Back to cited text no. 11
    
12.
Thorand B, Baumert J, Chambless L, Meisinger C, Kolb H, Döring A, et al.; MONICA/KORA Study Group. Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population. Arterioscler Thromb Vasc Biol 2006;26:398-405.  Back to cited text no. 12
    
13.
Ferri C, Bellini C, Desideri G, Giuliani E, De Siati L, Cicogna S, et al. Clustering of endothelial markers of vascular damage in human salt-sensitive hypertension: Influence of dietary sodium load and depletion. Hypertension 1998;32:862-8.  Back to cited text no. 13
    
14.
Nasuno A, Matsubara T, Hori T, Higuchi K, Imai S, Nakagawa I, et al. Levels of soluble E-selectin and ICAM-1 in the coronary circulation of patients with stable coronary artery disease: Association with the severity of coronary atherosclerosis. Jpn Heart J 2002;43:93-101.  Back to cited text no. 14
    
15.
Bevilacqua MP, Stengelin S, Gimbrone MA Jr, Seed B. Endothelial leukocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989;243:1160-5.  Back to cited text no. 15
    
16.
Gearing AJ, Hemingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: Pathological significance. Ann NY Acad Sci 1992;667:324-31.  Back to cited text no. 16
    
17.
Issac MS, Afif A, Gohar NA, Fayek NA, Zayed B, Sedrak H, et al. Association of E-selectin gene polymorphism and serum PAPP-A with carotid atherosclerosis in end-stage renal disease. Mol Diagn Ther 2014;18:243-52.  Back to cited text no. 17
    
18.
Mochizuki K, Inoue S, Miyauchi R, Misaki Y, Shimada M, Kasezawa N, et al. Plasma sE-selectin level is positively correlated with neutrophil count and diastolic blood pressure in Japanese men. J Nutr Sci Vitaminol (Tokyo) 2013;59:447-53.  Back to cited text no. 18
    
19.
Malberti F. Hyperphosphataemia: Treatment options. Drugs 2013;73:673-88.  Back to cited text no. 19
    
20.
Kumar R, Thompson JR. The regulation of parathyroid hormone secretion and synthesis. J Am Soc Nephrol 2011;22:216-24.  Back to cited text no. 20
    
21.
Voormolen N, Noordzij M, Grootendorst DC, Beetz I, Sijpkens YW, van Manen JG, et al.; PREPARE study group. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 2007;22:2909-16.  Back to cited text no. 21
    
22.
Lumachi F, Zanella S, Cella G, Casonato A, Fallo F. Endothelial activation markers soluble E-selectin and von Willebrand factor in primary hyperparathyroidism.In Vivo 2011;25:279-82.  Back to cited text no. 22
    
23.
Pecoits-Filho R, Heimbürger O, Bárány P, Suliman M, Fehrman-Ekholm I, Lindholm B, et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 2003;41:1212-8.  Back to cited text no. 23
    
24.
Garg AX, Clark WF, Haynes RB, House AA. Moderate renal insufficiency and the risk of cardiovascular mortality: Results from the NHANES I. Kidney Int 2002;61:1486-94.  Back to cited text no. 24
Advanced Biomedical Research
Volume 2016, july
July 2016
Pages 1-4